Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

196 Mon, 7/29/2019, 11:35 AM - 12:20 PM CC-Hall C
SPEED: Biometrics and Biostatistics Part 2 — Contributed Poster Presentations
Biometrics Section, Section on Statistics in Epidemiology, Biopharmaceutical Section, Section on Bayesian Statistical Science
Chair(s): Wendy Meiring, University of California At Santa Barbara
Oral Presentations for this session.
21: Oversampling and Replacement Strategies in Propensity Score Matching: a Critical Review Focused on Small Samples
Daniele Bottigliengo, University of Padova; Ileana Baldi, University of Padova; Corrado Lanera, University of Padova; Jonida Bejko, University of Brescia; Tomaso Bottio, University of Padova; Vincenzo Tarzia, University of Padova; Massimiliano Carrozzini, University of Padova; Gino Gerosa, University of Padova; Paola Berchialla, University of Torino; Dario Gregori, University of Padova
22: A Concordance Statistic for Survival Analysis with a Censored Predictor
Kai Ding, University of Oklahoma Health Sciences Center; Justin Dvorak, University of Oklahoma Health Sciences Center
23: Meta-Analysis of Binary Outcomes Combining Individual Patient Data and Aggregate Data
Neha Agarwala, University of Maryland - Baltimore County; Anindya Roy, University of Maryland - Baltimore County
24: Multiplicity Adjustment in Clinical Trials
Michael Proschan, National Institute of Allergy and Infectious Diseases; Erica Brittain, National Institute of Allergy and Infectious Diseases
25: A Comparison of Stacked and Pooled Multiple Imputation
Paul Bernhardt, Villanova University
26: Hierarchical Likelihood Approach for Joint Models of Longitudinal Non-Survival Responses and Survival Data: a Semiparametric Model with Gamma Shared Random Effects
Karl Stessy Bisselou, University of Nebraska Medical Center; Hongying Dai, University of Nebraska Medical Center; Gleb Haynatzki, University of Nebraska Medical Center
27: A Scalable Algorithm for Joint Modeling of Longitudinal and Competing Risks Time-To-Event Data
Shanpeng Li, UCLA Department of Biostatistics; Eric Kawaguchi, UCLA Department of Biostatistics; Gang Li, UCLA
28: Synthetic Data Method to Incorporate External Information into a Current Study
Tian Gu, University of Michigan; Jeremy Taylor, University of Michigan; Bhramar Mukherjee, University of Michigan
29: Predicting the Cross-Validated Penalty Parameter in Nodewise Lasso Regression
Mo Huang, University of Pennsylvania; Nancy Zhang, University of Pennsylvania
30: Statistical Assessment of Bovine Body Weight via Functional Gait Data
Andrew Raim, US Census Bureau; Nagaraj Neerchal, University of Maryland, Baltimore County; Dan Tasch, Step Analysis LLC; Uri Tasch, Step Analysis LLC
31: Adaptive Design with Biomarker Population Deselection and Enrichment for Oncology Trials
Pingye Zhang; Yue Shentu, Merck & Co., Inc.; Qi Liu, Merck & Co., Inc.
32: Unblinded Sample Size Re-Estimation for Ordinal Data
Huaihou Chen, Biogen; Ray Zhang, Biogen; Weihua Tang, Biogen; Li Zhu, Biogen; Chunlei Ke, Biogen
34: A Natural Lead-In Approach to Response-Adaptive Allocation
Erin Donahue, Virginia Commonwealth University; Roy T Sabo, Virginia Commonwealth University
35: Survival Analyzes in the Presence of Unadjudicated Events
Rakhi Kilaru, Pharmaceutical Product Development; Andrew Montgomery Hartley, Pharmaceutical Product Development
36: Design of a Phase 3 Trial for an Acute Treatment of a Rare Disease with Episodic Attacks
Sharon Murray
37: Bayesian Modeling of Rare Events with Informative Censoring in Meta-Analysis
Xinyue Qi, UT MD Anderson Cancer Center; Yucai Wang, Mayo Clinic; Chan Shen, College of Medicine, Penn State University; Michael Wang, The University of Texas MD Anderson Cancer Center; Shouhao Zhou, PennState College of Medicine
38: Bayesian Analysis of Mixed Continuous and Time-To-Event Outcomes with Latent Variables
Xinyuan Song, The Chinese University of Hong Kong; Deng Pan, Huazhong University of Science and Technology
39: A Bayesian Approach with Propensity Score for Confounding Control with Case Study in Non-Medical Switch Real World Observational Studies
Zhenyi Xue, AbbVie; Hongwei Wang, AbbVie Inc.
40: Quantitative Decision Making (QDM) in Phase I/II Studies
Kevin Gan, GlaxoSmithKline; Jonathan Haddad , GlaxoSmithKline